Primary study · included by 3 reviews

Analysis of the current status and influencing factors of oral frailty in elderly patients with type 2 diabetes mellitus in Taiyuan, China

Tian et al. 2025 · Tian Chun, Li Na, Gao Ya, et al. · BMC Geriatrics · 2025

Included by

Systematic review and meta-analysis of oral frailty prevalence among older hospitalized patients.
Non-Cochrane · prognostic · 2025 · cited as Tian et al. 2025 · Table 1; reference 50
Outcome this study informsPooled effectEvidenceCertainty
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Excluding any single study gave estimated prevalence ranging from 0.41 to 0.464 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.51 [0.47, 0.55]27 studies · 11575 participantsGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.62 [0.57, 0.66]3 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.50 [0.44, 0.56]19 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.52 [0.48, 0.57]23 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.51 [0.41, 0.61]6 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.50 [0.43, 0.56]13 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.45 [0.37, 0.53]5 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.48 [0.42, 0.53]3 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.42 [0.32, 0.51]3 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.42 [0.36, 0.48]4 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.52 [0.47, 0.57]14 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.52 [0.48, 0.56]22 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.54 [0.49, 0.60]8 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.39 [0.32, 0.47]3 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Sequentially removing each study left the overall prevalence statistically consistent with 0.5126 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty (condition of interest; no intervention) vs None (single-group prevalence)
Prevalence 0.52 [0.47, 0.57]8 studiesGRADE not reported
The prevalence and associated factors of oral frailty in older Chinese patients with chronic conditions: a systematic review and meta-analysis.
Non-Cochrane · prognostic · 2026 · cited as Tian 2025 · Supplementary Material 2 (Table 2); reference 21
Outcome this study informsPooled effectEvidenceCertainty
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 52.45 [41.67, 63.23]7 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 53.13 [38.21, 68.04]11 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 53.11 [41.45, 64.76]6 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 43.32 [38.62, 48.02]2 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 66.22 [53.09, 79.34]8 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 60.06 [39.68, 80.44]7 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Sensitivity analysis of oral frailty prevalence showed no significant difference in the pooled prevalence when any individual study was removed.16 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 47.86 [36.32, 59.40]7 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 57.18 [41.05, 73.31]5 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 55.14 [46.23, 63.88]16 studies · 5045 participantsGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 59.66 [25.73, 93.60]4 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 59.62 [44.50, 74.74]9 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 54.33 [52.95, 55.71]16 studies · 5045 participantsGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 42.67 [34.67, 50.67]8 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 59.54 [42.94, 76.14]9 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 52.22 [39.99, 64.45]6 studiesGRADE not reported
Prevalence of oral frailty (OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence (%) 45.09 [32.11, 58.07]6 studiesGRADE not reported
A systematic review and meta-analysis of the prevalence and risk factors of oral frailty among older adults.
Non-Cochrane · prognostic · 2026 · cited as Tian 2025 · Table 1; reference list
Outcome this study informsPooled effectEvidenceCertainty
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 24.9 [17.3, 33.4]10 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 29.2 [15.7, 44.9]5 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 39.4 [31.3, 47.8]6 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 19.2 [10.6, 29.5]4 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 20.6 [12.1, 30.6]8 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Older age (per 1-year increase) vs Per 1-year lower age
OR 1.10 [1.08, 1.11]6 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 43.3 [34.8, 52.0]8 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 48.7 [35.2, 62.3]5 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 34.7 [26.3, 43.7]13 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty assessed by OFI-6 or OFI-8
OR (meta-regression) 0.80 [0.68, 0.93]15 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty assessed by OFI-6 or OFI-8
OR (meta-regression) 0.84 [0.65, 1.09]15 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 27.9 [17.4, 39.8]9 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 32 [25, 41]15 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 29.1 [19.7, 39.5]7 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Physical frailty (frail) vs Non-frail
OR 2.55 [1.41, 4.62]4 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty assessed by OFI-6 or OFI-8
OR (meta-regression) 1.11 [0.93, 1.33]15 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 47.6 [37.6, 57.8]7 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 20.6 [14.6, 27.4]7 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 35.5 [21.0, 51.5]8 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty assessed by OFI-6 or OFI-8
OR (meta-regression) 1.07 [0.89, 1.28]15 studiesGRADE not reported
Oral frailty (OFI-6 or OFI-8)
Not applicable (prevalence) vs Not applicable
Prevalence 20.5 [18.7, 22.5]2 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty assessed by OFI-6 or OFI-8
OR (meta-regression) 0.77 [0.68, 0.87]15 studiesGRADE not reported
Prevalence of oral frailty
Oral frailty assessed by OFI-6 or OFI-8
OR (meta-regression) 1.24 [1.08, 1.43]15 studiesGRADE not reported

3 including reviews in total.